Navigation Links
Developing HIV fighter

Researchers developed a form of RNA which silencesd the genes that play a role in HIV infection, potentially showing a new way to combat the virus that causes AIDS. The team used short forms of RNA - ribonucleic acid - that turn off genes vital for the production of proteins used by the virus to enter and infect cells. RNA carries the blueprint for constructing proteins.//

Dr. Phillip Sharp, at the University of Texas, said that, if many obstacles can be surmounted this could be a basis for intervention in HIV treatment. The work was conducted in the laboratory, and problems to be solved include finding ways to deliver the RNA to cells in animals or humans, to ensure it would not interfere with normal biological processes and would not have side effects.

The work, reported Sunday in the online edition of the journal Nature Medicine, is a ``proof of concept,'' Sharp said. He won the 1993 Nobel Prize for the discovery of ``split genes,'' that changed how scientists look at evolution and advanced research on hereditary diseases, including some cancers. Dr. Louis M. Mansky of Ohio State University, who was not part of the research team, said the findings were interesting but he said ``there are a lot of concerns as to how it would be applicable.''

Mansky said there have been difficulties in getting similar strategies to work in clinical settings. In lab tests, the RNA reduced, but did not eliminate, the virus, and thus Mansky said it might be useful in addition to the current drugs used to combat AIDS.

RNA is present in most cells, carrying genetic information and operating in the production of proteins. In recent years scientists have discovered that double stranded RNA can silence genes in a process called RNA interference. The component that accomplishes this - small interfering RNA, or siRNA . Sharp's team made two different siRNAs that targeted cell surface proteins essential for the HIV virus to infect a cell. They tar geted the parts of the virus that make the protein as well as a regulator protein.

According to Sharp, in both cases we were able to show that these small RNAs in cells would inhibit the infection by HIV,'' in laboratory work.The RNA interference process is a very new development in biological science and is quite exciting,'' he said. ``It will move out of the lab soon ... in the next several years.''


'"/>




Related medicine news :

1. Risk Of Developing Arthritis
2. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
3. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
4. Men Who at Risk Of Developing Prostate Cancer
5. Identifying The Risks Of Developing Schizophrenia
6. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
7. Cancer Patients At A Greater Risk Of Developing Blood Clots
8. Young Smokers at Increased Risk Of Developing a Heart Attack
9. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
10. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
11. Risk Of Developing Infections High In Patients Who Suffer From Abdominal Trauma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
Breaking Medicine Technology: